Molecular diagnosis of a laboratory mouse papillomavirus (MusPV)

Joongho Joh1, A Bennett Jenson, Mary Proctor

  • 1Department of Medicine, James Graham Brown Cancer Center (JGBCC), USA.

Insights

A novel mouse papillomavirus (MusPV) was identified in laboratory mice. This study details diagnostic methods to detect MusPV infections and serological responses in mice, crucial for research settings.

Area of Science:

  • Veterinary Virology
  • Oncology
  • Molecular Biology

Background:

  • A novel papillomavirus, MusPV, has been identified in laboratory mice.
  • This virus may evade standard pathogen screening protocols in mouse colonies globally.
  • Understanding MusPV is critical for maintaining the health of research animal populations.

Purpose of the Study:

  • To characterize MusPV and develop reliable diagnostic assays for its detection.
  • To establish methods for identifying both active MusPV infections and immune responses in mice.
  • To ensure accurate screening of laboratory mice for MusPV to prevent research interference.

Main Methods:

  • Isolation and characterization of MusPV from infected nude mice.
  • Histopathological examination of lesions, including koilocytosis and electron microscopy for viral particles.
  • Immunohistochemistry using canine PV antiserum to detect viral antigens.
  • Rolling circle amplification and endonuclease digestion for viral DNA analysis.
  • Polymerase chain reaction (PCR) using degenerate and specific primer sets (My09/11 and MusPV-My09/11).
  • Southern blot analysis to confirm viral DNA presence.
  • Generation of virus-like particles (VLPs) for serological assays.

Main Results:

  • MusPV infections present with characteristic papillomas and histological features of papillomavirus infection.
  • Conserved PV antigens were detected in infected cells.
  • Both degenerate (My09/11) and a newly designed specific primer set (MusPV-My09/11) successfully detected MusPV DNA.
  • Southern blot confirmed the presence of full-length PV DNA.
  • VLPs were successfully generated for serological testing, enabling detection of immune responses.

Conclusions:

  • A comprehensive suite of diagnostic assays has been developed and validated for MusPV.
  • These methods can detect MusPV in skin tumors and assess serological responses in laboratory mice.
  • The developed assays are essential for accurate screening and management of MusPV in research settings.

Related Concept Videos